Characterizing Lipid‐Coated Mesoporous Silica Nanoparticles as CD169‐Binding Delivery System for Rilpivirine and Cabotegravir

Herein, lipid‐coated mesoporous silica nanoparticles (LMSNs) are investigated as biomimetic delivery vehicle for two antiretroviral (ARV) compounds, rilpivirine (RPV), and cabotegravir (CAB). Monosialodihexosylganglioside (GM3) is incorporated into the membrane to facilitate LMSN binding to CD169 (S...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Han Zang, Josiane Fofana, Fangda Xu, Sarah B. Nodder, Suryaram Gummuluru, Björn M. Reinhard
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley-VCH 2022-05-01
coleção:	Advanced NanoBiomed Research
Assuntos:	antiretroviral drugs drug delivery lipid-coated mesoporous silica nanoparticles
Acesso em linha:	https://doi.org/10.1002/anbr.202100157
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!